Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
The paper by Kroman et al on factors influencing the effect of
age on prognosis in breast cancer has important implications for
service delivery,1 increased amounts of chemotherapy being required for young women. The authors imply that only women at high
risk received adjuvant chemotherapy. In all, 36.3% of their 867 patients under 35 were in the low risk group, an excess mortality being
associated with not receiving chemotherapy.
We used the Yorkshire Cancer Registry (now part of the Northern and Yorkshire Cancer Registration and Information Service) to investigate the uptake of chemotherapy in this group of patients over the 15 years from 1980 to 1994 and determine its effect on survival.
Only 304 (19.8%) of the 1534 patients under 35 received adjuvant
chemotherapy. Their overall five year survival rate was 60% (95%
confidence interval 54.8 to 65.8) compared with 63% (60.6 to 66.0) in
those who did not receive chemotherapy. When 41 patients who presented
with overt